BofA Securities Starts Syndax Pharmaceuticals (SNDX) at Buy, 'strong NT outlook'
Tweet Send to a Friend
(Updated - October 25, 2023 6:15 AM EDT)
BofA Securities analyst Jason Zemansky initiates coverage on Syndax Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Jason Zemansky initiates coverage on Syndax Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
